纤维化
癌症研究
信号转导
过氧化物酶体
慢性移植物肾病
肾
化学
细胞生物学
炎症
生物发生
医学
肾脏疾病
受体
细胞器生物发生
转化生长因子
下调和上调
肺纤维化
肾病
线粒体生物发生
生物
刺猬信号通路
上皮-间质转换
过氧化物酶体增殖物激活受体
自噬
作者
Dan Zhang,Yang-He Zhang,Bin Liu,Hongxia Yang,Guangtao Li,Honglan Zhou,Yishu Wang,Zhi‐Xiang Xu
标识
DOI:10.1016/j.bbadis.2025.168066
摘要
Interstitial fibrosis is a key factor affecting the long-term survival of renal allografts. The Toll-like receptor 4 (TLR4)-nuclear factor kappa B (NF-κB) signaling pathway is widely activated in renal allografts, inducing inflammation and playing a pivotal role in the progression of fibrosis. However, it remains unclear whether NF-κB activation promotes renal allograft fibrosis through non-inflammatory mechanisms. In this study, we identified a negative correlation between NF-κB expression and peroxisomal biogenesis factor 5 (PEX5). In both rat renal allograft models and human kidney-2 (HK-2) cells, TLR4/NF-κB signaling suppressed PEX5 expression, leading to impaired peroxisome biogenesis and dysfunction. Mechanistically, TLR4/NF-κB signaling downregulated PEX5 expression by upregulating DNA methyltransferase 1 (DNMT1), and pharmacological inhibition of NF-κB or DNMT1 restored PEX5 levels. Peroxisomal dysfunction promoted epithelial-to-mesenchymal transition (EMT) and impaired the ability of peroxisomes to clear hydrogen peroxide, thereby accelerating fibrosis progression. Notably, pharmacological inhibition of DNMT1 effectively delayed the progression of fibrosis in renal allografts. In conclusion, these findings demonstrate that the NF-κB/DNMT1/PEX5 signaling pathway suppresses peroxisome biogenesis in renal allografts, and the amelioration of allograft fibrosis by pharmacologic DNMT1 inhibition underscores the translational relevance of this pathway. Targeting this pathway may provide a potential therapeutic strategy to improve renal allograft survival.
科研通智能强力驱动
Strongly Powered by AbleSci AI